Browsing Artículos (Bioquímica Médica y Biología Molecular e Inmunología) by Subject "HER2-negative"
Now showing items 1-1 of 1
-
Article
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
(BMC, 2023)Background: We evaluated a new chemoimmunotherapy combination based on the anti-PD1 monoclonal antibody pembrolizumab and ...